WO2010007247A2 - Use of an aqueous or organic or aqueous-organic extract of microsorum - Google Patents

Use of an aqueous or organic or aqueous-organic extract of microsorum Download PDF

Info

Publication number
WO2010007247A2
WO2010007247A2 PCT/FR2009/000854 FR2009000854W WO2010007247A2 WO 2010007247 A2 WO2010007247 A2 WO 2010007247A2 FR 2009000854 W FR2009000854 W FR 2009000854W WO 2010007247 A2 WO2010007247 A2 WO 2010007247A2
Authority
WO
WIPO (PCT)
Prior art keywords
extract
microsorum
composition
use according
aqueous
Prior art date
Application number
PCT/FR2009/000854
Other languages
French (fr)
Other versions
WO2010007247A3 (en
Inventor
Alain Meybeck
Raimana Ho
Taivini Teai
Phila Raharivelomanana
Original Assignee
Am Phyto-Conseil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Am Phyto-Conseil filed Critical Am Phyto-Conseil
Publication of WO2010007247A2 publication Critical patent/WO2010007247A2/en
Publication of WO2010007247A3 publication Critical patent/WO2010007247A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]

Definitions

  • the present invention aims to the use of an aqueous extract or ORGAM 'that or hydro-organic Microsorum for the manufacture of a cosmetic composition for skin care or hair.
  • Metua pua 'a is the vernacular name of certain common ferns in Tahiti as in other Polynesian islands and in particular Microsorum scolopendria and Microsorum membranifolium of the Polypodiaceae family (Ho R et al, Communication at the IV International Symposium on Aromatic Plants and Médicinales d'Outre-Mer, Tahiti, French Polynesia, 2006, as well as Ho R et al, Communication at the XVIth International Ecdysone Workshop, Ghent, Belgium, 2006). These plants contain in particular ecdysteroids.
  • Microsorum scolopendria contains ecdysone and 20-hydroxy-ecdysone alongside other ecdysteroids (Snogan E et al., Phytochem, Anal., 18, 441-450, 2007) and Microsorum membranifolium further contains 2- deoxy-20-hydroxyecdysone (Ho R et al., J Chromatogr Sci 46, 102-110, 2008). These ferns are used as ornamental plants.
  • fronds (leaves) and rhizomes of Metua pua 'a are used as ingredients for the preparation of traditional remedies used in particular as a purgative or vermifuge (Pétard P, Useful plants of Polynesia, pp 78- 80. Raau Tahiti , 1986. Haere po no Tahiti).
  • SA beta galactosidase a particular enzyme called "senally associated beta galactosidase” or SA beta, characterized by being active at pH 6 (Dimri GP et al, Proc Nat Acad Sci USA, 92: 9363-67, 1995).
  • SA beta a particular enzyme called "senally associated beta galactosidase” or SA beta, characterized by being active at pH 6 (Dimri GP et al, Proc Nat Acad Sci USA, 92: 9363-67, 1995).
  • the object of the present invention is to use an aqueous or organic or hydro-organic extract of Microsorum for the manufacture of a cosmetic composition for skincare or hair care.
  • Metua pua 'a is the vernacular name of certain common ferns in Tahiti as in other Polynesian islands and in particular Microsorum scolopendria and Microsorum membranifolium of the Polypodiaceae family (Ho R et al, Communication at the IV International Symposium on Aromatic Plants and Médicinales d'Outre-Mer, Tahiti, French Polynesia, 2006, as well as Ho R et al, Communication at the XVIth International Ecdysone Workshop, Ghent, Belgium, 2006). These plants contain in particular ecdysteroids.
  • Microsorum scolopendria contains ecdysone and 20-hydroxy-ecdysone alongside other ecdysteroids (Snogan E et al., Phytochem, Anal., 18, 441-450, 2007) and Microsorum membranifolium further contains 2- deoxy-20-hydroxyecdysone (Ho R et al., J Chromatogr Sci 46, 102-110, 2008). These ferns are used as ornamental plants.
  • fronds (leaves) and rhizomes of Metua pua 'a are used as ingredients for the preparation of traditional remedies used in particular as a purgative or vermifuge (Pétard P, Useful plants of Polynesia, pp 78- 80. Raau Tahiti , 1986. Haere po no Tahiti).
  • heme-oxygenase or HO-I is known. This enzyme catalyzes the degradation of Theme to carbon monoxide, free iron, and biliverdin (Pae H-O et al, J. Clin Biochem Nutr 42, 197-203, 2008). Carbon monoxide CO is now recognized as an important mediator, particularly responsible for the photo-immunoprotection of Langerhans cells by UVA radiation in the skin (Allanson et al., J Invest Dermatol, 124, 664-50, 2005). Iron that could be dangerously pro-oxidant in the free state is immediately complexed by a specialized protein called ferritin.
  • Biliverdin is rapidly converted by biliverdin reductase to bilirubin, a potent antioxidant (Stocker R et al., Science 235, 1043-6, 1987, Bach FH, Wien Klin Wienschr, 114, 1-3, 2002).
  • heme-oxygenase and ferritin play an important protective role in the body and it would be very advantageous to have substances that can activate their expression in cutaneous cells.
  • Another object of the invention is to provide a product whose active ingredient is natural. ' These and other objects which will become apparent in the present invention are achieved by the use of an aqueous or organic or hydroorganic extract of Microsorum for the manufacture of a composition for the care of the skin. skin or hair likely to activate the expression in the cells of heme-oxygenase HO-I and ferritin.
  • Microsorum is selected from the species commutatum, grossum, maximum, membranifolium, punctatum, rubidum, scolopendria, and more particularly membranifolium and scolopendria.
  • composition for the care of the skin or hair is according to the present invention is a cosmetic product for protection against the effects of oxidative stress.
  • the Microsorum extract is a sling or rhizome extract made with one or more of the following solvents: water, methanol, ethanol, propanol, butanol, propylene glycol, butylene glycol.
  • the final concentration expressed as Microsorum solids in the cosmetic composition is from 0.001 to 10% by weight and even more particularly from 0.05 to 1% by weight.
  • the cosmetic composition also contains at least one active substance such as an ascorbic acid derivative, a tocopherol, a tocopherol derivative, a retinol derivative, forskolin, caffeine, serine, glycerol, resveratrol, Centella extract, Ginseng extract, Notoginseng extract, Rhodiola extract, Eleutherococcus extract, Glycyrrhiza extract, Scutellaria extract, Griffonia extract, arbutin, kojic acid, a UV filter.
  • active substance such as an ascorbic acid derivative, a tocopherol, a tocopherol derivative, a retinol derivative, forskolin, caffeine, serine, glycerol, resveratrol, Centella extract, Ginseng extract, Notoginseng extract, Rhodiola extract, Eleutherococcus extract, Glycyrrhiza extract, Scutellaria extract, Griffonia extract, arbutin, kojic acid, a UV filter.
  • the cosmetic composition is in the form of an oil-in-water emulsion, a water-in-oil emulsion, a multiple emulsion, a lotion, a gel, a suspension of liposomes, a suspension of lipid spherules.
  • an aqueous or hydro-ethanolic Microsorum extract is used for a composition for the care of the skin or hair as a composition for the oral route.
  • one object of the present invention is the production of new cosmetic products for protecting the skin against aging, characterized in that they contain Microsorum extracts such as Microsorum scolopendria, or Microsorum m ⁇ mbranifolium, and more particularly extracts of rhizome and slingshot (leaf): it has in fact been surprisingly found that a particular fraction of an extract of Microsorum is likely to protect the skin cells against the appearance of "senescence".
  • Microsorum extracts such as Microsorum scolopendria, or Microsorum m ⁇ mbranifolium
  • rhizome and slingshot leaf
  • a solvent which can extract the relatively polar compounds without extracting too many free sugars or very hydrophobic substances.
  • Methanol is a good compromise, but you can also use a water-ethanol mixture or hot water.
  • a hot methanol extract it is possible after evaporation to carry out an extraction with an apolar solvent to remove colored products such as carotenoids and degradation products of chlorophyll still present in the leaves.
  • extraction with hot water it is possible after drying to partition with butanol in order to collect the less polar compounds and to get rid of the sugars.
  • dispersions of a fatty phase are generally chosen in water or vice versa, so as to gather in the formula a maximum of ingredients intended to give the product easy spreading properties. , a given consistency, a pleasant final touch, a good stability, a protection against microbial contaminations ...
  • a given consistency a pleasant final touch, a good stability, a protection against microbial contaminations ...
  • we will prefer more complicated formulations such as multiple emulsions or liposomes, or on the contrary simpler such as lotions or aqueous gels.
  • Example 1 Obtaining a Gross Extract from Microsorum scolopendria.
  • Example 2 Obtaining a Butanolic Fraction of the Gross Microsorum scolopendria Extract (M. scolopendrid). 146.5 g of dry methanol crude extract as in Example 1 are prepared from 715 g of dry Microsorum scolopendria fronds.
  • This dry extract is taken up in one equivalent of methanol, one equivalent of chloroform, and one equivalent of water. This gives two phases that are allowed to settle. The polar phase is separated and concentrated to give 28.21 g.
  • This dry polar phase is taken up in 200 ml of water before the addition of 200 ml of n-butanol.
  • fronds (leaves) of Microsorum scolopendria are macerated for 24 h in 100 ml of a mixture of water and ethanol 1 to 1 by volume. After filtration, the extract is evaporated to dryness. The dry extract is taken up in 50 ml of ethanol at 96 ° to prepare an ethanolic fraction. It is filtered through celite, and the ethanol is evaporated to obtain the dry ethanolic fraction of Microsorum scolopendria.
  • EXAMPLE 4 Obtaining a Microsorum membranifolium Raw Extract 30 g of dried fronds (leaves) of Microsorum membranifolium are extracted cold for one day with 100 ml of methanol. The extract is then dried by evaporation of the solvent in a rotary flask to give 6 g of crude extract of M. membranifolium.
  • Example 5 Obtaining a crude extract of Microsorum membranifolium.
  • Example 6 Qualitative test of activity on cutaneous cells of Microsorum scolopendria extracts. Normal human fibroblasts are cultured for 48 h in medium
  • DMEM fetal calf serum
  • DMSO fetal calf serum
  • 10 mg / ml of M. scolopendria crude extract of Example I 5 or 2 ug / ml of the butanol fraction from M. scolopendria of Example 2 were added via a stock solution in DMSO, 10 mg / ml of M. scolopendria crude extract of Example I 5 or 2 ug / ml of the butanol fraction from M. scolopendria of Example 2, and incubated for 24 h, as well as control cultures without extract.
  • a differential analysis of the expression of the genes in the fibroblasts is carried out by means of alignments of complementary DNA sequences ("c-DNA arrays") deposited on a polyamide membrane. For this, total RNA messengers extracted and then the "reverse transcribed” by using a mixture of primers corresponding to the c-DNA deposited on the membrane in the presence of labeled deoxynucleotide triphosphate to radioactive phosphorus 33 P. Thus labeled DNA sequences are prepared, and can then be "hybridized” to the target c-DNAs deposited in excess on the membrane.
  • the c-DNA alignments are revealed by autoradiography and the resulting spots are subjected to an image analysis which by comparison with a series of control genes, gives a semi-quantitative assessment of genes that are over-expressed or under-expressed. -expressed in the cells.
  • Example 5 quantitative RT-PCR analysis was performed.
  • the total messenger RNAs of the culture treated with the crude M. scolopendria extract of Example 5 were subjected to a polymerase chain reaction (PCR) in a Roche Molecular Systems Light Cycler®. Ihc.
  • PCR polymerase chain reaction
  • This system includes a thermo-cycler optimized for extremely fast PCR reactions, and a fluorometer to evaluate at 521 nm, the SYBR Green I dye which is specifically inserted between the DNA double helices at each cycle of duplication.
  • the following "primer" couples were used:
  • Heme-oxygenase I (HO-I, gene code bank NM-002133)
  • Ferritin (FTH1, gene code bank NM-002032).
  • G3PDH glyceraldehyde-3-phosphate dehydrogenase
  • Dermal fibroblasts of the same BJ strain as used by Chainaux F. et al., J. Biochem, Cell Biol 34 (11): 1331-9,2002) are cultured by conventional methods.
  • the fibroblasts are exposed once a day to a dose of 200 B / cm 2 of UV-B.
  • the culture medium is replaced with medium containing 50, 125, and 250 ⁇ g / ml of fraction F Bu M.s ..
  • the cells After the last irradiation, the cells are left for 72 hours in contact with medium supplemented with F Bu of M.s, renewed every 24 hours.
  • beta-galactosidase activity at pH6 (beta-galactosidase associated with senescence or SA beta-gal) is evaluated according to the method of Dirnri GP et al (already cited), on at least 400 cells for each concentration in F Bu of Ms.
  • Composition No. 1 anti-aging skin care cream.
  • the procedure is as for the production of a conventional oil-in-water emulsion, that is to say that a hydrophobic phase and an aqueous phase containing each of the raw materials intended to impart the product to the product are mixed with stirring at 85 ° C. Usual properties: stability, safety, easy spreading, nice final touch, etc.
  • the mixture is then cooled with stirring and at 50 ° C., 0.5% of crude Microsorum scolopendria extract is added as in Example 1. The cooling is continued with stirring until the ordinary temperature is reached.
  • This cream is applied to the face, neck and hands, preferably in the morning so that the principle stimulating the natural defenses has time to penetrate to the living cells, to be in contact in the middle of the day when the intensities solar irradiation are at their maximum.
  • Composition No. 2 Cosmetic cream for protection against oxidative stress. As above, an oil-in-water emulsion containing retinol palmitate is produced; during cooling to 45 ° C., fractional extract of Microsorum scolopendria as in Example 2 is added, together with a glycolic extract of Scutellaria baicalensis in an amount sufficient to arrive at the concentrations by weight in the final composition of : - fractional extract of Microsorum scolopendria 0.2%
  • Composition N ° 3 Cosmetic cream for anti-aging protection and filter protection.
  • composition No. 1 As in Composition No. 1, an oil-in-water emulsion with an addition of titanium oxide sufficient to obtain an SPF protection factor equal to 6 is carried out, then an extract of Microsorum scolopendria is added as in Example 1. 1 with stirring at 45 ° C in an amount sufficient to obtain 0.4% by weight extract in the final preparation. .
  • composition N ° 4 Anti-aging cosmetic gel for sensitive skin.
  • a hydroalcoholic acrylic gel is titrated with 0.3% by weight of Microsorum membranifolium extract as in Example 4 and containing in addition 2% by weight of glycolic acid extract of Glycyrrhiza glabra.
  • Composition N ° 5 Moisturizing cream for anti-aging protection.
  • composition 1 an oil-in-water emulsion containing 0.5% of Microsorum membranifolium extract of Example 5, 3% of glycerol and 1% of serine is prepared, these three constituents being added to the manufacture during cooling, when the temperature has reached 50 °.
  • composition N ° 6 Anti-hair loss lotion
  • a hydroalcoholic hair fall protection lotion containing 0.5% of Microsorum scolopendria extract as in Example 1 and 0.1% of Panax Notoginseng rhizome saponins is prepared.
  • Composition No. 7 Dietary supplement to protect the skin before exposure to the sun or pollution. 5 mg tablets per tablet of dry ethanolic fraction of a 1: 1 ethanolic extract of Microsorum scolopendria are prepared by conventional techniques as in Example 3.
  • Composition N ° 8 Food supplement drink to protect the skin during sun exposure.
  • a coconut water drink containing 0.01% by weight of dry ethanolic fraction of Microsorum scolopendria extract is prepared as in Example 3.
  • This drink is presented in doses of 100 ml. It is advisable to drink a dose each morning at breakfast.

Abstract

The invention relates to the use of an aqueous or organic or aqueous-organic extract of Microsorum for the manufacture of a cosmetic skincare or haircare composition, in particular for anti-ageing protection against the effects of oxidative stress or of ultraviolet radiation.

Description

Utilisation d'un extrait aqueux ou organique ou hydro-organique de Microsorum. Use of an aqueous or organic or hydro-organic extract of Microsorum.
La présente invention a pour but l'utilisation d'un extrait aqueux ou orgam'que ou hydro-organique de Microsorum pour la fabrication d'une composition cosmétique de soin de la peau ou du cheveu.The present invention aims to the use of an aqueous extract or ORGAM 'that or hydro-organic Microsorum for the manufacture of a cosmetic composition for skin care or hair.
Metua pua' a est le nom vernaculaire de certaines fougères communes à Tahiti comme dans d'autres îles Polynésiennes et en particulier de Microsorum scolopendria et Microsorum membranifolium de la famille des Polypodiaceae (Ho R et al, Communication au IVème Colloque International sur les Plantes Aromatiques et Médicinales d'Outre-Mer, Tahiti, Polynésie Française, 2006 ; ainsi que Ho R et al, Communication au XVIème International Ecdysone Workshop, Ghent, Belgique, 2006). Ces plantes contiennent en particulier des ecdystéroïdes. Par exemple Microsorum scolopendria contient de l' ecdysone et de la 20-hydroxy-ecdysone à côté d'autres ecdystéroïdes (Snogan E et al, Phytochem. Anal. 18, 441-450, 2007) et Microsorum membranifolium contient en outre la 2-deoxy-20-hydroxyecdysone (Ho R et al, J Chromatogr Sci 46, 102-110, 2008). Ces fougères sont utilisées comme plantes ornementales. De plus, les frondes (feuilles) et les rhizomes de Metua pua' a, sont utilisés comme ingrédients pour la préparation de remèdes traditionnels utilisés en particulier comme purgatif ou vermifuge (Pétard P, Plantes utiles de Polynésie, pp 78- 80. Raau Tahiti, 1986. Haere po no Tahiti).Metua pua 'a is the vernacular name of certain common ferns in Tahiti as in other Polynesian islands and in particular Microsorum scolopendria and Microsorum membranifolium of the Polypodiaceae family (Ho R et al, Communication at the IV International Symposium on Aromatic Plants and Médicinales d'Outre-Mer, Tahiti, French Polynesia, 2006, as well as Ho R et al, Communication at the XVIth International Ecdysone Workshop, Ghent, Belgium, 2006). These plants contain in particular ecdysteroids. For example Microsorum scolopendria contains ecdysone and 20-hydroxy-ecdysone alongside other ecdysteroids (Snogan E et al., Phytochem, Anal., 18, 441-450, 2007) and Microsorum membranifolium further contains 2- deoxy-20-hydroxyecdysone (Ho R et al., J Chromatogr Sci 46, 102-110, 2008). These ferns are used as ornamental plants. In addition, the fronds (leaves) and rhizomes of Metua pua 'a, are used as ingredients for the preparation of traditional remedies used in particular as a purgative or vermifuge (Pétard P, Useful plants of Polynesia, pp 78- 80. Raau Tahiti , 1986. Haere po no Tahiti).
Par ailleurs, on sait que le vieillissement, et notamment le vieillissement des tissus conjonctifs, tels que la peau, est dû en grande partie à l'apparition de cellules à l'état « sénescent » qui sécrètent des enzymes susceptibles de dégrader la matrice extracellulaire, des cytŒ-jptës pro inflammatoires, et des facteurs de croissance (Campisi J et d'Adda di Fagagna F, Nature Reviews Mol CeIl Biol. 8, 729-740, 2007). Il a en effet été établi lors d'études de réplication de cultures de cellules, ainsi que lors d'études de cellules de peaux de personnes âgées, que les cellules cutanées peuvent passer dans un état bien particulier qualifié de « sénescent » par les spécialistes en Biologie Cellulaire. Dans cet état, elles ne peuvent plus se reproduire, et elles expriment une enzyme particulière appelée « bêta galactosidase associée à la sénescence » ou SA bêta- gal, caractérisée par le fait qu'elle est active à pH 6 (Dimri GP et al, Proc Nat Acad Sci USA, 92 : 9363-67, 1995). Utilisation d'un extrait aqueux ou organique ou hydro-organique de Microsorum.Moreover, it is known that aging, and in particular the aging of connective tissues, such as the skin, is largely due to the appearance of "senescent" cells that secrete enzymes capable of degrading the extracellular matrix. pro-inflammatory cytokines, and growth factors (Campisi J and Adda di Fagagna, Nature Reviews Mol CeIl Biol 8, 729-740, 2007). It has indeed been established in cell culture replication studies, as well as in studies of skin cells of the elderly, that the skin cells can pass into a very specific state described as "senescent" by specialists. in Cell Biology. In this state, they can no longer reproduce, and they express a particular enzyme called "senally associated beta galactosidase" or SA beta, characterized by being active at pH 6 (Dimri GP et al, Proc Nat Acad Sci USA, 92: 9363-67, 1995). Use of an aqueous or organic or hydro-organic extract of Microsorum.
La présente invention a pour but l'utilisation d'un extrait aqueux ou organique ou hydro-organique de Microsorum pour la fabrication d'une composition cosmétique de soin de la peau ou du cheveu.The object of the present invention is to use an aqueous or organic or hydro-organic extract of Microsorum for the manufacture of a cosmetic composition for skincare or hair care.
Metua pua' a est le nom vernaculaire de certaines fougères communes à Tahiti comme dans d'autres îles Polynésiennes et en particulier de Microsorum scolopendria et Microsorum membranifolium de la famille des Polypodiaceae (Ho R et al, Communication au IVème Colloque International sur les Plantes Aromatiques et Médicinales d'Outre-Mer, Tahiti, Polynésie Française, 2006 ; ainsi que Ho R et al, Communication au XVIème International Ecdysone Workshop, Ghent, Belgique, 2006). Ces plantes contiennent en particulier des ecdystéroïdes. Par exemple Microsorum scolopendria contient de l' ecdysone et de la 20-hydroxy-ecdysone à côté d'autres ecdystéroïdes (Snogan E et al, Phytochem. Anal. 18, 441-450, 2007) et Microsorum membranifolium contient en outre la 2-deoxy-20-hydroxyecdysone (Ho R et al, J Chromatogr Sci 46, 102-110, 2008). Ces fougères sont utilisées comme plantes ornementales. De plus, les frondes (feuilles) et les rhizomes de Metua pua' a, sont utilisés comme ingrédients pour la préparation de remèdes traditionnels utilisés en particulier comme purgatif ou vermifuge (Pétard P, Plantes utiles de Polynésie, pp 78- 80. Raau Tahiti, 1986. Haere po no Tahiti).Metua pua 'a is the vernacular name of certain common ferns in Tahiti as in other Polynesian islands and in particular Microsorum scolopendria and Microsorum membranifolium of the Polypodiaceae family (Ho R et al, Communication at the IV International Symposium on Aromatic Plants and Médicinales d'Outre-Mer, Tahiti, French Polynesia, 2006, as well as Ho R et al, Communication at the XVIth International Ecdysone Workshop, Ghent, Belgium, 2006). These plants contain in particular ecdysteroids. For example Microsorum scolopendria contains ecdysone and 20-hydroxy-ecdysone alongside other ecdysteroids (Snogan E et al., Phytochem, Anal., 18, 441-450, 2007) and Microsorum membranifolium further contains 2- deoxy-20-hydroxyecdysone (Ho R et al., J Chromatogr Sci 46, 102-110, 2008). These ferns are used as ornamental plants. In addition, the fronds (leaves) and rhizomes of Metua pua 'a, are used as ingredients for the preparation of traditional remedies used in particular as a purgative or vermifuge (Pétard P, Useful plants of Polynesia, pp 78- 80. Raau Tahiti , 1986. Haere po no Tahiti).
Par ailleurs, on sait que le vieillissement, et notamment le vieillissement des tissus conjonctifs, tels que la peau, est dû en grande partie à l'apparition de cellules à l'état « sénescent » qui sécrètent des enzymes susceptibles de dégrader la matrice extracellulaire, des cytokines pro inflammatoires, et des facteurs de croissance (Campisi J et d'Adda di Fagagna F, Nature Reviews Mol CeIl Biol. 8, 729-740, 2007). Il a en effet été établi lors d'études de réplication de cultures de cellules, ainsi que lors d'études de cellules de peaux de personnes âgées, que les cellules cutanées peuvent passer dans un état bien particulier qualifié de « sénescent » par les spécialistes en Biologie Cellulaire. Dans cet état, elles ne peuvent plus se reproduire, et elles expriment une enzyme particulière appelée « bêta galactosidase associée à la sénescence » ou SA bêta- gal, caractérisée par le fait qu'elle est active à pH 6 (Dimri GP et al, Proc Nat Acad Sci USA, 92 : 9363-67, 1995). Enfin il apparaît que les « cellules sénescentes » in vivo peuvent avoir des effets néfastes sur le tissu environnant (Funk W.D. et al, Exp CeIl Res.258 :270-8) et qu'il parait important de disposer de moyens pour éviter leur apparition.Moreover, it is known that aging, and in particular the aging of connective tissues, such as the skin, is largely due to the appearance of "senescent" cells that secrete enzymes capable of degrading the extracellular matrix. pro-inflammatory cytokines and growth factors (Campisi J and Adda di Fagagna F, Nature Reviews Mol CeIl Biol 8, 729-740, 2007). It has indeed been established in cell culture replication studies, as well as in studies of skin cells of the elderly, that the skin cells can pass into a very specific state described as "senescent" by specialists. in Cell Biology. In this state, they can no longer reproduce, and they express a particular enzyme called "senally associated beta galactosidase" or SA beta, characterized by being active at pH 6 (Dimri GP et al, Proc Nat Acad Sci USA, 92: 9363-67, 1995). Finally, it appears that the "senescent cells" in vivo may have adverse effects on the surrounding tissue (Funk WD et al, Exp CeIl Res.258: 270-8) and that it seems important to have means to avoid their appearance. .
Il semble donc qu'il serait très intéressant de pouvoir disposer de moyens pour éviter l'apparition de « cellules sénescentes » qui ont perdu la capacité de se reproduire, et qui ont des effets néfastes sur les tissus environnants.It seems that it would be very interesting to have means to avoid the appearance of "senescent cells" that have lost the ability to reproduce, and have adverse effects on the surrounding tissues.
D'autre part, on sait que la peau des zones exposées, et en particulier la peau du visage, vieillit plus rapidement en raison des stress oxydatifs provoqués par les rayonnements ultra violets et la pollution atmosphérique qui engendrent des radicaux libres, des peroxydes, de l'oxygène singulet et de l'ion superoxyde, qui peuvent dégrader dans l'organisme les protéines (enzymes, protéines de structure...), les lipides des membranes biologiques, les acides nucléiques... . C'est la raison pour laquelle il convient de protéger ces zones de peau par des produits cosmétiques adaptés.On the other hand, it is known that the skin of the exposed areas, and in particular the skin of the face, ages more rapidly because of the oxidative stress caused by ultraviolet radiation and atmospheric pollution which generate free radicals, peroxides, singlet oxygen and superoxide ion, which can degrade in the body proteins (enzymes, structural proteins ...), lipids of biological membranes, nucleic acids .... This is the reason why these skin areas should be protected by suitable cosmetic products.
Par ailleurs on connaît l'enzyme hème-oxygénase ou HO-I. Cette enzyme catalyse la dégradation de Thème en monoxyde de carbone, en fer libre, et en biliverdine (Pae H-O et al, J Clin Biochem Nutr. 42, 197-203, 2008). Le monoxyde de carbone CO est maintenant reconnu comme un important médiateur, en particulier responsable de la photo-inrmunoprotection des cellules de Langerhans par les rayonnements UVA dans la peau (Allanson et al, J Invest Dermatol. 124,644-50, 2005). Le fer qui pourrait être dangereusement pro-oxydant à l'état libre est immédiatement complexé par une protéine spécialisée appelée ferritine. La biliverdine est transformée rapidement par la biliverdine réductase en bilirubine, un puissant antioxydant (Stocker R et al, Science. 235, 1043-6, 1987 ; Bach FH, Wien Klin Wochenschr . 114, 1-3, 2002). Ainsi l'hème-oxygénase et la ferritine jouent dans l'organisme un rôle protecteur important et il serait très intéressant de disposer de substances susceptibles d'activer leur expression dans les cellules cutanées.Moreover, the enzyme heme-oxygenase or HO-I is known. This enzyme catalyzes the degradation of Theme to carbon monoxide, free iron, and biliverdin (Pae H-O et al, J. Clin Biochem Nutr 42, 197-203, 2008). Carbon monoxide CO is now recognized as an important mediator, particularly responsible for the photo-immunoprotection of Langerhans cells by UVA radiation in the skin (Allanson et al., J Invest Dermatol, 124, 664-50, 2005). Iron that could be dangerously pro-oxidant in the free state is immediately complexed by a specialized protein called ferritin. Biliverdin is rapidly converted by biliverdin reductase to bilirubin, a potent antioxidant (Stocker R et al., Science 235, 1043-6, 1987, Bach FH, Wien Klin Wochenschr, 114, 1-3, 2002). Thus, heme-oxygenase and ferritin play an important protective role in the body and it would be very advantageous to have substances that can activate their expression in cutaneous cells.
Aussi un des buts de la présente invention est-il de stimuler, dans les cellules cutanées, la biosynthèse de certaines protéines entrant en jeu dans leur protection contre les stress oxydatifs, en particulier l'hème-oxygénase HO-I et la ferritine.It is therefore an object of the present invention to stimulate, in cutaneous cells, the biosynthesis of certain proteins involved in their protection against oxidative stress, in particular HO-I heme-oxygenase and ferritin.
Un autre but de l'invention est de fournir un produit dont le principe actif est naturel. ' Ces buts, ainsi que d'autres qui apparaîtront par la suite sont atteints, selon la présente invention, par l'utilisation d'un extrait aqueux ou organique ou hydro- organique de Microsorum pour la fabrication d'une composition pour le soin de la peau ou du cheveu susceptible d'activer l'expression dans les cellules de l'hème-oxygénase HO-I et de la ferritine.Another object of the invention is to provide a product whose active ingredient is natural. ' These and other objects which will become apparent in the present invention are achieved by the use of an aqueous or organic or hydroorganic extract of Microsorum for the manufacture of a composition for the care of the skin. skin or hair likely to activate the expression in the cells of heme-oxygenase HO-I and ferritin.
De préférence, le Microsorum est choisi parmi les espèces commutatum, grossum, maximum, membranifolium, punctatum, rubidum, scolopendria, et plus particulièrement membranifolium et scolopendria.Preferably, Microsorum is selected from the species commutatum, grossum, maximum, membranifolium, punctatum, rubidum, scolopendria, and more particularly membranifolium and scolopendria.
Avantageusement, la composition pour le soin de la peau ou du cheveu est selon la présente invention est un produit cosmétique de protection contre les effets des stress oxydatifs.Advantageously, the composition for the care of the skin or hair is according to the present invention is a cosmetic product for protection against the effects of oxidative stress.
Selon un mode préféré de réalisation de la présente invention, l'extrait de Microsorum est un extrait de fronde ou de rhizome réalisé avec un ou plusieurs des solvants suivants : eau, méthanol, éthanol, propanol, butanol, propylène glycol, butylène glycol.According to a preferred embodiment of the present invention, the Microsorum extract is a sling or rhizome extract made with one or more of the following solvents: water, methanol, ethanol, propanol, butanol, propylene glycol, butylene glycol.
De préférence, la concentration finale exprimée en extrait sec de Microsorum dans la composition cosmétique est de 0,001 à 10 % en poids et même plus particulièrement de 0,05 à 1 % en poids.Preferably, the final concentration expressed as Microsorum solids in the cosmetic composition is from 0.001 to 10% by weight and even more particularly from 0.05 to 1% by weight.
Avantageusement, la composition cosmétique contient également au moins une substance active telle qu'un dérivé d'acide ascorbique, un tocophérol, un dérivé de tocophérol, un dérivé de rétinol, la forskoline, la caféine, la serine, le glycérol, le resvératrol, un extrait de Centella, un extrait de Ginseng, un extrait de Notoginseng, un extrait de Rhodiola, un extrait d'Eleutherococcus, un extrait de Glycyrrhiza, un extrait de Scutellaria, un extrait de Griffonia, l'arbutine, l'acide kojique, un filtre UV . De préférence, la composition cosmétique est sous la forme d'une émulsion huile dans eau, d'une émulsion eau dans huile, d'une émulsion multiple, d'une lotion, d'un gel, d'une suspension de liposomes, d'une suspension de sphérules lipidiques.Advantageously, the cosmetic composition also contains at least one active substance such as an ascorbic acid derivative, a tocopherol, a tocopherol derivative, a retinol derivative, forskolin, caffeine, serine, glycerol, resveratrol, Centella extract, Ginseng extract, Notoginseng extract, Rhodiola extract, Eleutherococcus extract, Glycyrrhiza extract, Scutellaria extract, Griffonia extract, arbutin, kojic acid, a UV filter. Preferably, the cosmetic composition is in the form of an oil-in-water emulsion, a water-in-oil emulsion, a multiple emulsion, a lotion, a gel, a suspension of liposomes, a suspension of lipid spherules.
Avantageusement, on utilise un extrait aqueux ou hydro-éthanolique de Microsorum d'une composition pour le soin de la peau ou du cheveu comme composition pour la voie orale.Advantageously, an aqueous or hydro-ethanolic Microsorum extract is used for a composition for the care of the skin or hair as a composition for the oral route.
Ainsi, la présente invention a notamment pour but la réalisation de nouveaux produits cosmétiques pour protéger la peau contre le vieillissement caractérisés en ce qu'ils contiennent des extraits de Microsorum tels que Microsorum scolopendria, ou Microsorum mβmbranifolium, et plus particulièrement des extraits de rhizome et de fronde (feuille) : il a été en effet trouvé de façon surprenante qu'une fraction particulière d'un extrait de Microsorum est susceptible de protéger les cellules cutanées contre l'apparition de la « sénescence ».Thus, one object of the present invention is the production of new cosmetic products for protecting the skin against aging, characterized in that that they contain Microsorum extracts such as Microsorum scolopendria, or Microsorum mβmbranifolium, and more particularly extracts of rhizome and slingshot (leaf): it has in fact been surprisingly found that a particular fraction of an extract of Microsorum is likely to protect the skin cells against the appearance of "senescence".
Pour l'obtention des extraits, on choisit un solvant susceptible d'extraire les composés relativement polaires sans extraire trop de sucres libres ou de substances très hydrophobes. Le méthanol est un bon compromis, mais on peut aussi utiliser un mélange eau-éthanol ou l'eau chaude. Dans le cas d'un extrait au méthanol chaud, on pourra après évaporation réaliser une extraction avec un solvant apolaire pour éliminer des produits colorés tels que les caroténoïdes et les produits de dégradation de la chlorophylle toujours présents dans les feuilles. Dans le cas d'une extraction à l'eau chaude, on peut après séchage réaliser une partition avec le butanol pour recueillir les composés moins polaires et se débarrasser des sucres. Pour la réalisation des compositions cosmétiques, on choisit en général des dispersions d'une phase grasse dans l'eau ou l'inverse, de manière à rassembler dans la formule un maximum d'ingrédients destinés à conférer au produit des propriétés d'étalement facile, une consistance donnée, un toucher final agréable, une bonne stabilité, une protection contre les contaminations microbiennes ... Dans certains cas on préférera des formulations plus compliquées telles que les émulsions multiples ou les liposomes, ou au contraire plus simples telles que les lotions ou les gels aqueux.In order to obtain the extracts, a solvent is selected which can extract the relatively polar compounds without extracting too many free sugars or very hydrophobic substances. Methanol is a good compromise, but you can also use a water-ethanol mixture or hot water. In the case of a hot methanol extract, it is possible after evaporation to carry out an extraction with an apolar solvent to remove colored products such as carotenoids and degradation products of chlorophyll still present in the leaves. In the case of extraction with hot water, it is possible after drying to partition with butanol in order to collect the less polar compounds and to get rid of the sugars. For the production of cosmetic compositions, dispersions of a fatty phase are generally chosen in water or vice versa, so as to gather in the formula a maximum of ingredients intended to give the product easy spreading properties. , a given consistency, a pleasant final touch, a good stability, a protection against microbial contaminations ... In certain cases we will prefer more complicated formulations such as multiple emulsions or liposomes, or on the contrary simpler such as lotions or aqueous gels.
La description, qui va suivre et qui ne présente aucun caractère limitatif, est en particulier relative à des exemples de réalisation qui permettront à l'homme du métier de mieux comprendre la présente invention.The following description, which is in no way limiting, relates in particular to exemplary embodiments which will enable those skilled in the art to better understand the present invention.
Exemple 1 : Obtention d'un Extrait Brut de Microsorum scolopendria.Example 1: Obtaining a Gross Extract from Microsorum scolopendria.
50 g de frondes (feuilles) séchées de Microsorum scolopendria {M. scolopendria) sont extraits au soxhlet par 100 ml de méthanol pendant deux fois 7 heures.50 g of dried fronds (leaves) from Microsorum scolopendria {M. scolopendria) are extracted with soxhlet per 100 ml of methanol for two times 7 hours.
L'extrait méthanolique est évaporé à l'évaporateur rotatif pour donner 10,25 g d'Extrait Brut sec. Exemple 2 : Obtention d'une Fraction Butanolique de l'extrait brut de Microsorum scolopendria (M. scolopendrid). On prépare 146,5 g d'extrait brut méthanolique sec tel qu'à l'Exemple 1 à partir de 715 g de frondes sèches de Microsorum scolopendria.The methanol extract is evaporated on a rotary evaporator to give 10.25 g of dry crude extract. Example 2: Obtaining a Butanolic Fraction of the Gross Microsorum scolopendria Extract (M. scolopendrid). 146.5 g of dry methanol crude extract as in Example 1 are prepared from 715 g of dry Microsorum scolopendria fronds.
Cet extrait sec est repris par un équivalent de méthanol, un équivalent de chloroforme, et un équivalent d'eau. On obtient ainsi deux phases que l'on laisse décanter. La phase polaire est séparée, puis concentrée pour donner 28,21 g.This dry extract is taken up in one equivalent of methanol, one equivalent of chloroform, and one equivalent of water. This gives two phases that are allowed to settle. The polar phase is separated and concentrated to give 28.21 g.
Cette phase polaire sèche est reprise par 200 ml d'eau avant l'ajout de 200 ml de n-butanol.This dry polar phase is taken up in 200 ml of water before the addition of 200 ml of n-butanol.
On sépare la phase organique, puis on l'évaporé pour obtenir 1,25 g. Cette fraction sèche est alors reprise par 2 ml d'un mélange eau-éthanol 3 :1 et passée pour purification sur une colonne de gel polyamide (47 x 3 cm) avec le même mélange hydro-alcoolique comme solvant. Le premier volume de solvant de 300 ml correspond au volume mort de la colonne et n'est pas retenu. Le deuxième volume de 300 ml d'éluat est recueilli et évaporé pour donner 500 mg de Fraction Butanolique sèche d'extrait de Microsorum scolopendria.The organic phase is separated and evaporated to give 1.25 g. This dry fraction is then taken up in 2 ml of a 3: 1 water-ethanol mixture and passed for purification on a polyamide gel column (47 × 3 cm) with the same hydro-alcoholic mixture as solvent. The first 300 ml solvent volume corresponds to the dead volume of the column and is not retained. The second volume of 300 ml of eluate is collected and evaporated to give 500 mg of dry Butanolic Fraction of Microsorum scolopendria extract.
Exemple 3 : Obtention d'une fraction éthanolique de Microsorum scolopendria.Example 3 Obtaining an Ethanolic Fraction of Microsorum scolopendria
50 g de frondes (feuilles) de Microsorum scolopendria sont macérées pendant 24 h dans 100 ml d'un mélange d'eau et d'éthanol 1 à 1 en volume. Après filtration, on évapore l'extrait à sec. On reprend l'extrait sec par 50 ml d'éthanol à 96° pour prépare une fraction éthanolique. On filtre sur Celite, et on évapore l'éthanol pour obtenir la fraction éthanolique sèche de Microsorum scolopendria.50 g of fronds (leaves) of Microsorum scolopendria are macerated for 24 h in 100 ml of a mixture of water and ethanol 1 to 1 by volume. After filtration, the extract is evaporated to dryness. The dry extract is taken up in 50 ml of ethanol at 96 ° to prepare an ethanolic fraction. It is filtered through celite, and the ethanol is evaporated to obtain the dry ethanolic fraction of Microsorum scolopendria.
Exemple 4 : Obtention d'un Extrait Brut de Microsorum membranifolium. 30 g de frondes (feuilles) séchées de Microsorum membranifolium sont extraits à froid pendant un jour par 100 ml de méthanol. L'extrait est ensuite séché par évaporation du solvant au ballon rotatif pour donner 6 g d'extrait brut de M. membranifolium.EXAMPLE 4 Obtaining a Microsorum membranifolium Raw Extract 30 g of dried fronds (leaves) of Microsorum membranifolium are extracted cold for one day with 100 ml of methanol. The extract is then dried by evaporation of the solvent in a rotary flask to give 6 g of crude extract of M. membranifolium.
Exemple 5 : Obtention d'un extrait brut de Microsorum membranifolium.Example 5 Obtaining a crude extract of Microsorum membranifolium.
100 g de rhizomes secs de Microsorum membranifolium sont broyés, puis extraits avec 300 ml d'un mélange d'eau et d'éthanol 1/1 en volume. Après filtration, on évapore l'extrait à sec.100 g of dry rhizomes of Microsorum membranifolium are crushed, then extracted with 300 ml of a mixture of water and ethanol 1/1 by volume. After filtration, the extract is evaporated to dryness.
Exemple 6 : Test qualitatif d'activité sur les cellules cutanées des extraits de Microsorum scolopendria. Des fibroblastes humains normaux sont cultivés pendant 48 h dans du milieuExample 6: Qualitative test of activity on cutaneous cells of Microsorum scolopendria extracts. Normal human fibroblasts are cultured for 48 h in medium
DMEM supplémenté de 10 % de sérum de veau fœtal. Puis on ajoute à des aliquotes de la culture par l'intermédiaire d'une solution mère dans le DMSO, 10 μg/ml de l'extrait brut de M. scolopendria de l'Exemple I5 ou 2 μg/ml de la fraction butanolique de M. scolopendria de l'Exemple 2, et on laisse incuber ces cultures pendant 24 h, de même que des cultures de contrôle sans extrait.DMEM supplemented with 10% fetal calf serum. Then aliquots of culture were added via a stock solution in DMSO, 10 mg / ml of M. scolopendria crude extract of Example I 5 or 2 ug / ml of the butanol fraction from M. scolopendria of Example 2, and incubated for 24 h, as well as control cultures without extract.
Après 24 h de contact avec l'extrait ou la fraction à tester, on réalise une analyse différentielle de l'expression des gènes dans les fibroblastes au moyen d'alignements de séquences d'ADN complémentaires (« c-DNA arrays ») déposés sur une membrane de polyamide. Pour cela, on extrait les ARN messagers totaux, puis on les « reverse-transcrit » en utilisant un mélange d'amorces correspondant aux c-DNA déposés sur la membrane, en présence de déoxynucléotide-triphosphate marqué au phosphore radioactif 33P. Ainsi des séquences de d'ADN marquées sont préparées, et peuvent alors être «hybridées » sur les c-DNA cible déposés en excès sur la membrane. Après lavage, les alignements de c-DNA sont révélés par autoradiographie et les taches obtenues sont soumises à une analyse d'image qui par comparaison avec une série de gènes témoin, donne une appréciation semi-quantitative des gènes qui sont sur-exprimés ou sous-exprimés dans les cellules.After 24 hours of contact with the extract or the fraction to be tested, a differential analysis of the expression of the genes in the fibroblasts is carried out by means of alignments of complementary DNA sequences ("c-DNA arrays") deposited on a polyamide membrane. For this, total RNA messengers extracted and then the "reverse transcribed" by using a mixture of primers corresponding to the c-DNA deposited on the membrane in the presence of labeled deoxynucleotide triphosphate to radioactive phosphorus 33 P. Thus labeled DNA sequences are prepared, and can then be "hybridized" to the target c-DNAs deposited in excess on the membrane. After washing, the c-DNA alignments are revealed by autoradiography and the resulting spots are subjected to an image analysis which by comparison with a series of control genes, gives a semi-quantitative assessment of genes that are over-expressed or under-expressed. -expressed in the cells.
On a ainsi pu constater (Tableau 1) que les gènes de l'hème-oxygènase HO-I et de la ferritine étaient sur-exprimés dans la cultures de fibroblastes incubée en présence de l'extrait de M. scolopendria, mais pas de manière significative dans la culture traitée avec la fraction butanolique. Tableau 1It was thus found (Table 1) that the heme-oxygenase HO-I and ferritin genes were overexpressed in the fibroblast cultures incubated in the presence of the M. scolopendria extract, but not in such a manner. significant in the culture treated with the butanolic fraction. Table 1
Figure imgf000009_0001
Figure imgf000009_0001
Exemple 7 : Test quantitatif d'activité des extraits de M. scolopendria sur les cellules cutanées.EXAMPLE 7 Quantitative Activity Test of M. scolopendria Extracts on Cutaneous Cells
Pour confirmer les résultats de l'Exemple 5, une analyse par RT-PCR quantitative a été réalisée. Pour cela, les ARN messagers totaux de la culture traitée par l'extrait brut de M. scolopendria de l'Exemple 5 ont été soumis à une réaction en chaîne avec la polymérase (PCR) dans un « Light Cycler® » de Roche Molecular Systems Ihc. Ce système comprend un « thermo cycler » optimisé pour des réactions PCR extrêmement rapides, et un fluorimètre pour évaluer à 521 nm, le colorant SYBR Green I qui s'intercale de façon spécifique entre les double hélices d'ADN à chaque cycle de duplication. Les couples de « primer » suivants ont été utilisés :To confirm the results of Example 5, quantitative RT-PCR analysis was performed. For this, the total messenger RNAs of the culture treated with the crude M. scolopendria extract of Example 5 were subjected to a polymerase chain reaction (PCR) in a Roche Molecular Systems Light Cycler®. Ihc. This system includes a thermo-cycler optimized for extremely fast PCR reactions, and a fluorometer to evaluate at 521 nm, the SYBR Green I dye which is specifically inserted between the DNA double helices at each cycle of duplication. The following "primer" couples were used:
- Hème-oxygénase I (HO-I, code gène bank NM-002133)Heme-oxygenase I (HO-I, gene code bank NM-002133)
- Ferritine (FTHl, code gène bank NM-002032).Ferritin (FTH1, gene code bank NM-002032).
Le gène de la glycéraldehyde-3 -phosphate déhydrogénase (G3PDH) a été utilisé comme marqueur de référence. Les résultats exprimés en % de l'expression du gène considéré dans la culture traitée avec l'extrait brut de M. scolopendria, par rapport à la culture contrôle non- traitée sont donnés au Tableau 2.The glyceraldehyde-3-phosphate dehydrogenase (G3PDH) gene was used as a reference marker. The results expressed in% of the expression of the gene considered in the culture treated with the raw extract of M. scolopendria, compared to the non-treated control culture are given in Table 2.
Tableau 2Table 2
Figure imgf000009_0002
Ainsi l'extrait brut de Microsorum scolopendria active l'expression des gènes de l'hème-oxygénase et de la ferritine dans les fîbroblastes de peau.
Figure imgf000009_0002
Thus the crude extract of Microsorum scolopendria activates the expression of the genes of heme-oxygenase and ferritin in skin fibroblasts.
Exemple 8 : Test de prévention de la sénescence des cellules cutanées par Ia fraction butanolique d'un extrait de Microsorum scolopendria (F Bu de M.S.).EXAMPLE 8 Test for Prevention of Cutaneous Cell Senescence by the Butanolic Fraction of an Extract of Microsorum scolopendria (F Bu from M.S.)
Ce test met en évidence l'atténuation par la fraction butanolique de l'exemple 2 des dommages causés à des fîbroblastes en culture, par des stress oxydatifs répétés résultant d'expositions répétées à un rayonnement ultraviolet.This test demonstrates the attenuation by the butanolic fraction of Example 2 of the damage caused to fibroblasts in culture by repeated oxidative stress resulting from repeated exposure to ultraviolet radiation.
Des fîbroblastes de derme de la même souche BJ que celle utilisée par Chainiaux F. et al (firt. J. Biochem. CeIl. Biol. 34(11) : 1331-9,2002) sont mis en culture par les méthodes classiques.Dermal fibroblasts of the same BJ strain as used by Chainaux F. et al., J. Biochem, Cell Biol 34 (11): 1331-9,2002) are cultured by conventional methods.
L'absence de cytotoxicité de la fraction butanolique de l'exemple 2 sur une durée de 24 heures, est vérifiée dans la gamme 50 à 250 μg /ml.The absence of cytotoxicity of the butanol fraction of Example 2 over a period of 24 hours is verified in the range 50 to 250 μg / ml.
Pendant 5 jours les fibroblastes sont exposés 1 fois par jour à une dose d'uîtra- violets B de 200 mj/cm2.For 5 days, the fibroblasts are exposed once a day to a dose of 200 B / cm 2 of UV-B.
24 heures avant le premier traitement aux UV, et à la suite de chaque irradiation, le milieu de culture est remplacé par du milieu contenant 50, 125, et 250 μg /ml de fraction F Bu de M.s..24 hours before the first UV treatment, and following each irradiation, the culture medium is replaced with medium containing 50, 125, and 250 μg / ml of fraction F Bu M.s ..
Avant chaque nouvelle irradiation, ces milieux sont remplacés par un milieu ne contenant pas de fraction F Bu de M.s..Before each new irradiation, these media are replaced by a medium containing no fraction F Bu M.s ..
Après la dernière irradiation, les cellules sont laissées 72 heures en contact avec du milieu supplémenté en F Bu de M.s., renouvelé toutes les 24h.After the last irradiation, the cells are left for 72 hours in contact with medium supplemented with F Bu of M.s, renewed every 24 hours.
Au terme de cette dernière période de contact, l'activité bêta-galactosidase à pH6 (bêta-galactosidase associée à la sénescence ou SA bêta-gal) est évaluée suivant la méthode de Dirnri G.P. et al (déjà cité), sur au moins 400 cellules pour chaque concentration en F Bu de M.s..At the end of this last period of contact, the beta-galactosidase activity at pH6 (beta-galactosidase associated with senescence or SA beta-gal) is evaluated according to the method of Dirnri GP et al (already cited), on at least 400 cells for each concentration in F Bu of Ms.
L'expérience a été réalisée deux fois.The experiment was performed twice.
Les valeurs moyennes des pourcentages de cellules exprimant la SA bêta-gal sont regroupées dans le Tableau ci-après. Tableau 3The average values of the percentages of cells expressing beta-gal SA are summarized in the Table below. Table 3
Figure imgf000011_0001
Figure imgf000011_0001
On constate que : - les dommages causés par les expositions répétées aux rayons ultra-violets B ont entraîné une augmentation significative des fibroblastes présentant l'activité SA bêta- gal caractéristique des cellules qui ne peuvent plus se reproduire (qualifiées de « sénescentes »).It can be seen that: - the damage caused by repeated exposure to ultraviolet B rays has led to a significant increase in fibroblasts exhibiting the characteristic beta-galatic activity of cells that can no longer reproduce (termed "senescent").
- le traitement des cellules par la fraction butanolique de Microsorum scolopendria de l'exemple 2 avant et après les irradiations, a permis une atténuation des dommages causés par les ultra-violets dès la concentration de 50 μg/ml, ce qui se traduit par un nombre de fibroblastes « sénescents » qui reste inférieur à celui des cultures n'ayant subi aucune irradiation.the treatment of the cells with the butanolic fraction of Microsorum scolopendria of Example 2 before and after the irradiations, made it possible to attenuate the damage caused by the ultraviolet rays as early as the concentration of 50 μg / ml, which results in a number of "senescent" fibroblasts which remains lower than that of cultures that have not undergone any irradiation.
Il apparaît ainsi, que l'utilisation de la fraction d'extrait de Microsorum scolopendria, permet bien selon l'invention d'atténuer les dommages causés aux cellules cutanées par l'exposition répétée à un stress oxydatif.It thus appears that the use of the extract fraction of Microsorum scolopendria makes it possible, according to the invention, to attenuate the damage caused to cutaneous cells by repeated exposure to oxidative stress.
Composition N°l : Crème de soin de la peau anti-vieillissement.Composition No. 1: anti-aging skin care cream.
On procède comme pour la réalisation d'une émulsion classique huile dans eau, c'est-à-dire qu'on mélange sous agitation à 850C une phase hydrophobe et une phase aqueuse contenant chacune des matières premières destinées à conférer au produit les propriétés d'usage habituelles : stabilité, sécurité, étalement facile, toucher final agréable, etc. On refroidit ensuite sous agitation et à 5O0C, on rajoute 0,5 % d'extrait brut de Microsorum scolopendria tel qu'à l'Exemple 1. On continue le refroidissement sous agitation jusqu'à la température ordinaire.The procedure is as for the production of a conventional oil-in-water emulsion, that is to say that a hydrophobic phase and an aqueous phase containing each of the raw materials intended to impart the product to the product are mixed with stirring at 85 ° C. Usual properties: stability, safety, easy spreading, nice final touch, etc. The mixture is then cooled with stirring and at 50 ° C., 0.5% of crude Microsorum scolopendria extract is added as in Example 1. The cooling is continued with stirring until the ordinary temperature is reached.
Cette crème est appliquée sur le visage, le cou et les mains, de préférence le matin pour que le principe stimulant les défenses naturelles ait le temps de pénétrer jusqu'aux cellules vivantes, afin d'être en contact en milieu de journée quand les intensités d'irradiation UV solaires sont à leur maximum.This cream is applied to the face, neck and hands, preferably in the morning so that the principle stimulating the natural defenses has time to penetrate to the living cells, to be in contact in the middle of the day when the intensities solar irradiation are at their maximum.
Composition N°2 : Crème cosmétique de protection contre les stress oxydatifs. On réalise comme ci-dessus une émulsion huile dans eau contenant du palmitate de rétinol ; lors du refroidissement à 45°C, on rajoute de l'extrait fractionné de Microsorum scolopendria tel qu'à l'exemple 2, ainsi qu'un extrait glycolique de Scutellaria baicalensis en quantité suffisante pour arriver aux concentrations en poids dans la composition finale de : - extrait fractionné de Microsorum scolopendria 0,2 %Composition No. 2: Cosmetic cream for protection against oxidative stress. As above, an oil-in-water emulsion containing retinol palmitate is produced; during cooling to 45 ° C., fractional extract of Microsorum scolopendria as in Example 2 is added, together with a glycolic extract of Scutellaria baicalensis in an amount sufficient to arrive at the concentrations by weight in the final composition of : - fractional extract of Microsorum scolopendria 0.2%
- palmitate de rétinol 0,05 %retinol palmitate 0.05%
- extrait glycolique de Scutellaria baicalensis 2 %. Cette formulation est une crème de jour.- glycolic extract of Scutellaria baicalensis 2%. This formulation is a day cream.
Composition N°3 : Crème cosmétique de protection anti-vieillissement et de protection filtrante.Composition N ° 3: Cosmetic cream for anti-aging protection and filter protection.
On réalise comme pour la Composition N°l, une émulsion huile dans eau avec un ajout d'oxyde de titane suffisant pour obtenir un facteur de protection SPF égal à 6, puis on ajoute un extrait de Microsorum scolopendria tel qu'à l'Exemple 1 sous agitation à 45°C en quantité suffisante pour arriver à 0,4 % d'extrait en poids dans la préparation finale. .As in Composition No. 1, an oil-in-water emulsion with an addition of titanium oxide sufficient to obtain an SPF protection factor equal to 6 is carried out, then an extract of Microsorum scolopendria is added as in Example 1. 1 with stirring at 45 ° C in an amount sufficient to obtain 0.4% by weight extract in the final preparation. .
Le produit est destiné à être appliqué le matin sur les zones de peau non couvertes, et, si possible, l'application doit être renouvelée en milieu de journée. Composition N°4 : Gel cosmétique de protection anti-vieillissement, pour peaux sensibles.The product is intended to be applied in the morning on uncovered skin areas, and if possible, the application should be renewed mid-day. Composition N ° 4: Anti-aging cosmetic gel for sensitive skin.
On réalise un gel acrylique hydroalcoolique titré à 0,3 % en poids d'extrait de Microsorum membranifolium tel qu'à l'Exemple 4 et contenant en outre 2 % en poids d'extrait hydro glycolique de Glycyrrhiza glabra.A hydroalcoholic acrylic gel is titrated with 0.3% by weight of Microsorum membranifolium extract as in Example 4 and containing in addition 2% by weight of glycolic acid extract of Glycyrrhiza glabra.
Composition N°5 : Crème hydratante de protection anti-vieillissement.Composition N ° 5: Moisturizing cream for anti-aging protection.
On réalise comme pour la Composition 1 une émulsion huile dans eau contenant 0,5% d'extrait de Microsorum membranifolium de l'Exemple 5, 3% de glycérol, et 1% de serine, ces trois constituants étant rajoutés à la fabrication lors du refroidissement, lorsque la température a atteint 50°.As in Composition 1, an oil-in-water emulsion containing 0.5% of Microsorum membranifolium extract of Example 5, 3% of glycerol and 1% of serine is prepared, these three constituents being added to the manufacture during cooling, when the temperature has reached 50 °.
Composition N°6 : Lotion Capillaire AntichuteComposition N ° 6: Anti-hair loss lotion
On réalise une lotion capillaire hydro alcoolique antichute contenant 0,5 % d'extrait de Microsorum scolopendria tel qu'à l'Exemple 1 et 0,1 % de saponines de rhizome de Panax Notoginseng,A hydroalcoholic hair fall protection lotion containing 0.5% of Microsorum scolopendria extract as in Example 1 and 0.1% of Panax Notoginseng rhizome saponins is prepared.
Composition N°7 : Complément alimentaire pour protéger la peau avant toute exposition au soleil ou aux pollutions. On réalise par les techniques classiques des comprimés dosés à 5 mg par comprimé de fraction éthanolique sèche d'un extrait hydro éthanolique 1/1 de Microsorum scolopendria tel qu'à l'Exemple 3.Composition No. 7: Dietary supplement to protect the skin before exposure to the sun or pollution. 5 mg tablets per tablet of dry ethanolic fraction of a 1: 1 ethanolic extract of Microsorum scolopendria are prepared by conventional techniques as in Example 3.
Ces comprimés sont à prendre avec un peu d'eau au cours des repas du matin et de milieu de journée, à raison de un à deux comprimés par prise suivant l'intensité et la durée d'exposition attendue.These tablets should be taken with a little water during the morning and mid-day meals, one to two tablets per dose depending on the intensity and duration of exposure expected.
Composition N°8 : Boisson de complément alimentaire pour protéger la peau lors des expositions au soleil.Composition N ° 8: Food supplement drink to protect the skin during sun exposure.
On réalise une boisson à base d'eau de coco contenant 0,01 % en poids de fraction éthanolique sèche d'extrait de Microsorum scolopendria tel qu'à l'Exemple 3.A coconut water drink containing 0.01% by weight of dry ethanolic fraction of Microsorum scolopendria extract is prepared as in Example 3.
Cette boisson est présentée en doses de 100 ml. Il est conseillé d'en boire une dose chaque matin au petit déjeuner. This drink is presented in doses of 100 ml. It is advisable to drink a dose each morning at breakfast.

Claims

REVENDICATIONS
1. Utilisation d'un extrait aqueux ou organique ou hydro-organique de Microsorum pour la fabrication d'une composition pour le soin de la peau ou du cheveu susceptible d'activer l'expression dans les cellules de l'hème- oxygénase HO-I et de la ferritine.1. Use of an aqueous or organic or hydro-organic extract of Microsorum for the manufacture of a composition for the care of the skin or hair capable of activating the expression in the cells of heme-oxygenase HO- I and ferritin.
2. Utilisation selon la revendication 1 telle que le Microsorum est choisi parmi les espèces commutatum, grossum, maximum, membranifolium, punctatum, rubidum, scolopendria, et plus particulièrement membranifolium et scolopendria.2. Use according to claim 1, such that Microsorum is chosen from the species commutatum, grossum, maximum, membranifolium, punctatum, rubidum, scolopendria, and more particularly membranifolium and scolopendria.
3. Utilisation selon l'une des revendications 1 ou 2 telle que la composition pour le soin de la peau ou du cheveu est un produit cosmétique de protection contre les effets des stress oxydatifs.3. Use according to one of claims 1 or 2 such that the composition for the care of the skin or hair is a cosmetic product for protection against the effects of oxidative stress.
4. Utilisation selon l'une des revendications 1 à 3 telle que l'extrait de Microsorum est un extrait de fronde ou de rhizome réalisé avec un ou plusieurs des solvants suivants : eau, methanol, ethanol, propanol, butanol, propylène glycol, butylène glycol.4. Use according to one of claims 1 to 3 such that the Microsorum extract is a sling or rhizome extract made with one or more of the following solvents: water, methanol, ethanol, propanol, butanol, propylene glycol, butylene glycol.
5. Utilisation selon l'une des revendications 1 à 4 telle que la concentration finale exprimée en extrait sec de Microsorum dans la composition cosmétique est de 0,001 à 10 % en poids.5. Use according to one of claims 1 to 4 such that the final concentration expressed as Microsorum solids in the cosmetic composition is from 0.001 to 10% by weight.
6. Utilisation selon la revendication 5 telle que la concentration finale exprimée en extrait sec de Microsorum dans la composition cosmétique est plus particulièrement de 0,05 à 1 % en poids.6. Use according to claim 5 such that the final concentration expressed as microsorum solids in the cosmetic composition is more particularly from 0.05 to 1% by weight.
7. Utilisation selon l'une des revendications 1 à 6 telle que la composition cosmétique contient également au moins une substance active telle qu'un dérivé d'acide ascorbique, un tocophérol, un dérivé de tocophérol, un dérivé de retinol, la forskoline, la caféine, la serine, le glycérol, le resveratrol, un extrait de Centella, un extrait de Ginseng, un extrait de Notoginseng, un extrait de Rhodiola, un extrait d'Eleutherococcus, un extrait de Glycyrrhiza, un extrait de Scutellaria, un extrait de Griffonia, l'arbutine, l'acide kojique, un filtre UV .7. Use according to one of claims 1 to 6 such that the cosmetic composition also contains at least one active substance such as a ascorbic acid derivative, a tocopherol, a tocopherol derivative, a retinol derivative, forskolin, caffeine, serine, glycerol, resveratrol, a Centella extract, a Ginseng extract, a Notoginseng extract, a Rhodiola extract, an extract of Eleutherococcus, an extract of Glycyrrhiza, an extract of Scutellaria, a Griffonia extract, arbutin, kojic acid, a UV filter.
8. Utilisation selon l'une des revendications 1 à 7 telle que la composition cosmétique est sous la forme d'une émulsion huile dans eau, d'une émulsion eau dans huile, d'une émulsion multiple, d'une lotion, d'un gel, d'une suspension de liposomes, d'une suspension de sphérules lipidiques.8. Use according to one of claims 1 to 7 such that the cosmetic composition is in the form of an oil-in-water emulsion, a water-in-oil emulsion, a multiple emulsion, a lotion, a gel, a suspension of liposomes, a suspension of lipid spherules.
9. Utilisation d'un extrait aqueux ou hydroéthanolique de Microsorum selon les revendications 1 ou 2 telle que la composition pour le soin de la peau ou du cheveu est une composition pour la voie orale. 9. Use of an aqueous or aqueous ethanol extract Microsorum according to claims 1 or 2 such that the composition for the care of the skin or hair is a composition for the oral route.
PCT/FR2009/000854 2008-07-16 2009-07-10 Use of an aqueous or organic or aqueous-organic extract of microsorum WO2010007247A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR08/04044 2008-07-16
FR0804044A FR2933869B1 (en) 2008-07-16 2008-07-16 USE OF AN AQUEOUS OR ORGANIC OR HYDRO-ORGANIC MICROSORUM EXTRACT

Publications (2)

Publication Number Publication Date
WO2010007247A2 true WO2010007247A2 (en) 2010-01-21
WO2010007247A3 WO2010007247A3 (en) 2010-04-08

Family

ID=40386101

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2009/000854 WO2010007247A2 (en) 2008-07-16 2009-07-10 Use of an aqueous or organic or aqueous-organic extract of microsorum

Country Status (2)

Country Link
FR (1) FR2933869B1 (en)
WO (1) WO2010007247A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697672A (en) * 2012-06-05 2012-10-03 东南大学 Multiple emulsion of arbutin and preparation method thereof
WO2019125996A1 (en) 2017-12-20 2019-06-27 Figene, Llc Augmentation of fibroblast regenerative activity
CN111150670A (en) * 2020-01-15 2020-05-15 北京贝丽莱斯生物化学有限公司 Anti-ultraviolet and anti-blue-light liquid crystal nano-lipid liquid and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527777A (en) * 1968-03-05 1970-09-08 Ceskoslovenska Akademie Ved Method for obtaining ecdysterones
US5609873A (en) * 1992-08-25 1997-03-11 Lvmh Recherche Use of an ecdysteroid for the preparation of cosmetic or dermatological compositions intended, in particular, for strengthening the water barrier function of the skin or for the preparation of a skin cell culture medium, as well as to the compositions
FR2876032A1 (en) * 2004-10-05 2006-04-07 Greentech Sa Sa Use of extract of leaves, spores or roots of plants belonging to the group of Polypodiophytes (ferns) for cosmetic/dermopharmaceutical applications
FR2893843A1 (en) * 2005-11-25 2007-06-01 Am Phyto Conseil Sarl Use of a composition containing ecdysteroid or its derivative, or vegetable/animal extracts to stimulate natural defenses of the cells against the consequences of their exposure to UV radiations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4653361B2 (en) * 2001-09-20 2011-03-16 株式会社コーセー Skin preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527777A (en) * 1968-03-05 1970-09-08 Ceskoslovenska Akademie Ved Method for obtaining ecdysterones
US5609873A (en) * 1992-08-25 1997-03-11 Lvmh Recherche Use of an ecdysteroid for the preparation of cosmetic or dermatological compositions intended, in particular, for strengthening the water barrier function of the skin or for the preparation of a skin cell culture medium, as well as to the compositions
FR2876032A1 (en) * 2004-10-05 2006-04-07 Greentech Sa Sa Use of extract of leaves, spores or roots of plants belonging to the group of Polypodiophytes (ferns) for cosmetic/dermopharmaceutical applications
FR2893843A1 (en) * 2005-11-25 2007-06-01 Am Phyto Conseil Sarl Use of a composition containing ecdysteroid or its derivative, or vegetable/animal extracts to stimulate natural defenses of the cells against the consequences of their exposure to UV radiations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200365 Thomson Scientific, London, GB; AN 2003-683073 XP002518015 & JP 2003 095911 A (KOSE KK) 3 avril 2003 (2003-04-03) *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697672A (en) * 2012-06-05 2012-10-03 东南大学 Multiple emulsion of arbutin and preparation method thereof
WO2019125996A1 (en) 2017-12-20 2019-06-27 Figene, Llc Augmentation of fibroblast regenerative activity
EP4249586A3 (en) * 2017-12-20 2023-11-29 Figene, LLC Augmentation of fibroblast regenerative activity
US11959102B2 (en) 2017-12-20 2024-04-16 Figene, Llc Augmentation of fibroblast regenerative activity
CN111150670A (en) * 2020-01-15 2020-05-15 北京贝丽莱斯生物化学有限公司 Anti-ultraviolet and anti-blue-light liquid crystal nano-lipid liquid and preparation method thereof
CN111150670B (en) * 2020-01-15 2022-09-23 北京贝丽莱斯生物科技有限公司 Anti-ultraviolet and anti-blue-light liquid crystal nano-lipid liquid and preparation method thereof

Also Published As

Publication number Publication date
FR2933869A1 (en) 2010-01-22
WO2010007247A3 (en) 2010-04-08
FR2933869B1 (en) 2012-04-06

Similar Documents

Publication Publication Date Title
EP2662072B1 (en) Active ingredient obtained from Cichorium intybus for action on the skin barrier function similar to that of vitamin D
FR2924334A1 (en) COSMETIC COMPOSITION COMPRISING ASCORBIC 2-GLUCOSIDE ACID AND ERGOTHIONEIN
WO2019002714A1 (en) Cosmetic composition comprising an essential oil of immortelle and an extract of origanum
EP2953611A1 (en) Use of a composition comprising avocado perseose in the protection of epidermal stem cells
WO2004069218A1 (en) Use of verbascoside as a stimulant agent for the production of thermal shock proteins by the cells of the skin
EP3980124B1 (en) Extract of moringa peregrina seed cake, method for obtaining same and use thereof in cosmetic or nutricosmetic compositions
WO2010007247A2 (en) Use of an aqueous or organic or aqueous-organic extract of microsorum
WO2012117170A2 (en) Extract of winter branches of hippophae and use thereof in a cosmetic composition
EP3980123B1 (en) Moringa peregrina seed extract rich in 2,5-diformylfuran, process for obtaining same and use thereof in cosmetic compositions
FR3047171A1 (en) DIPROPYLENE GLYCOL ESTERS OF DICAFEOYLQUINIC ACIDS, VEGETABLE EXTRACT CONTAINING SAME, PROCESS FOR OBTAINING THE SAME AND USES THEREOF
EP3429695B1 (en) Coconut shell extracts, compositions containing same and uses
FR3067939A1 (en) EXTRACT FROM WITHANIA WILL SOMETHING TO FIGHT THE HARMFUL EFFECTS OF VISIBLE RADIATION ON THE SKIN
WO2018096039A1 (en) Extracts of plants from the tagetes genus and uses of same
WO2009138583A2 (en) Use of a composition containing ergosterol or a natural extract of a vegetable or animal microorganism
FR3066118A1 (en) EDULATED SECUMUM EXTRACT TO FIGHT THE HARMFUL EFFECTS OF ULTRAVIOLET RADIATION
EP1174120B1 (en) Use of an extract of an Iridaceae in an immune defenses stimulating composition
FR3076461A1 (en) Cosmetic composition of active prevention signs of age.
WO2019077268A1 (en) Cosmetic composition for active prevention of the signs of ageing
WO2024008902A1 (en) Anti-ageing cosmetic care composition comprising caulerpin
FR3059549B1 (en) COSMETIC USE OF AN EXTRACT FROM ULEX EUROPAEUS.
FR2924335A1 (en) Use of ascorbic acid 2-glucoside, as active ingredient in a cosmetic composition e.g. to mitigate effects of skin aging or delay the appearance of the effects, and to reduce or delay the formation of wrinkles and firmness of the skin
FR2893843A1 (en) Use of a composition containing ecdysteroid or its derivative, or vegetable/animal extracts to stimulate natural defenses of the cells against the consequences of their exposure to UV radiations
OA21067A (en) Moringa Peregrina seed extract rich in 2,5-diformylfuran, its process for obtaining it and its use in cosmetic compositions.
FR3110419A1 (en) Moringa peregrina seed extract rich in 2,5-diformylfuran, process for obtaining it and its use in cosmetic compositions
OA21068A (en) Moringa Peregrina seed cake extract, its production process and its use in cosmetic or nutricosmetic compositions.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09784262

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09784262

Country of ref document: EP

Kind code of ref document: A2